Loading
Latest filing published 17 May 2016 for Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation).
No signal scores available.
West Face Capital Inc. is a declared insider of Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation), with filings sourced from SEDI. Over a trading history stretching from 30 December 2015 to 13 May 2016, the count stands at 2 filings.
On the market, this insider has only sold: 1 sale. No amount is published for 1 filing, which the totals therefore leave out. Since January 2016: no purchases and 1 sale on the market.
Most recently, on 17 May 2016, the filings show a transaction in Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations